These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mitochondrial quality, dynamics and functional capacity in Parkinson's disease cybrid cell lines selected for Lewy body expression. Cronin-Furman EN; Borland MK; Bergquist KE; Bennett JP; Trimmer PA Mol Neurodegener; 2013 Jan; 8():6. PubMed ID: 23351342 [TBL] [Abstract][Full Text] [Related]
5. A cybrid cell model for the assessment of the link between mitochondrial deficits and sporadic Parkinson's disease. Arduíno DM; Esteves AR; Swerdlow RH; Cardoso SM Methods Mol Biol; 2015; 1265():415-24. PubMed ID: 25634293 [TBL] [Abstract][Full Text] [Related]
6. A genome on shaky ground: exploring the impact of mitochondrial DNA integrity on Parkinson's disease by highlighting the use of cybrid models. Lang M; Grünewald A; Pramstaller PP; Hicks AA; Pichler I Cell Mol Life Sci; 2022 May; 79(5):283. PubMed ID: 35513611 [TBL] [Abstract][Full Text] [Related]
7. Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence. Swerdlow RH Antioxid Redox Signal; 2012 May; 16(9):950-64. PubMed ID: 21338319 [TBL] [Abstract][Full Text] [Related]
9. Activation of p38 and N-acetylcysteine-sensitive c-Jun NH2-terminal kinase signaling cascades is required for induction of apoptosis in Parkinson's disease cybrids. Onyango IG; Tuttle JB; Bennett JP Mol Cell Neurosci; 2005 Mar; 28(3):452-61. PubMed ID: 15737736 [TBL] [Abstract][Full Text] [Related]
10. Biochemical analysis of cybrids expressing mitochondrial DNA from Contursi kindred Parkinson's subjects. Swerdlow RH; Parks JK; Cassarino DS; Binder DR; Bennett JP; Di Iorio G; Golbe LI; Parker WD Exp Neurol; 2001 Jun; 169(2):479-85. PubMed ID: 11358461 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background. Esteves AR; Domingues AF; Ferreira IL; Januário C; Swerdlow RH; Oliveira CR; Cardoso SM Mitochondrion; 2008 Jun; 8(3):219-28. PubMed ID: 18495557 [TBL] [Abstract][Full Text] [Related]
12. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Trimmer PA; Swerdlow RH; Parks JK; Keeney P; Bennett JP; Miller SW; Davis RE; Parker WD Exp Neurol; 2000 Mar; 162(1):37-50. PubMed ID: 10716887 [TBL] [Abstract][Full Text] [Related]
13. Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease. Ghosh SS; Swerdlow RH; Miller SW; Sheeman B; Parker WD; Davis RE Ann N Y Acad Sci; 1999; 893():176-91. PubMed ID: 10672237 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial respiration and respiration-associated proteins in cell lines created through Parkinson's subject mitochondrial transfer. Esteves AR; Lu J; Rodova M; Onyango I; Lezi E; Dubinsky R; Lyons KE; Pahwa R; Burns JM; Cardoso SM; Swerdlow RH J Neurochem; 2010 May; 113(3):674-82. PubMed ID: 20132468 [TBL] [Abstract][Full Text] [Related]
15. Differential Effects of Yeast NADH Dehydrogenase (Ndi1) Expression on Mitochondrial Function and Inclusion Formation in a Cell Culture Model of Sporadic Parkinson's Disease. Cronin-Furman EN; Barber-Singh J; Bergquist KE; Yagi T; Trimmer PA Biomolecules; 2019 Mar; 9(4):. PubMed ID: 30934776 [TBL] [Abstract][Full Text] [Related]
16. Characterization of cybrid cell lines containing mtDNA from Huntington's disease patients. Swerdlow RH; Parks JK; Cassarino DS; Shilling AT; Bennett JP; Harrison MB; Parker WD Biochem Biophys Res Commun; 1999 Aug; 261(3):701-4. PubMed ID: 10441489 [TBL] [Abstract][Full Text] [Related]